{"id": "1365296810827255808", "creation": 1614347100.0, "user_id": "2570920968", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "Novavax and Takeda Finalize License Agreement for Novavax\u2019 COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan! $NVAX $TAK #COVID19 #vaccine #Japan\nhttps://t.co/HPapjvvU8E https://t.co/r90IwrX46U", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#JAPAN"]}